Tech Company Financing Transactions
Nour Immune Funding Round
Nour Immune, operating out of Annapolis, received $75 thousand from TEDCO.
Transaction Overview
Company Name
Announced On
9/5/2010
Transaction Type
Venture Equity
Amount
$75,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Annapolis, MD 21401
USA
Annapolis, MD 21401
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Nour Immune Inc.is working with UMCP to create a proof of concept for the Federal Drug Administration (FDA), which will demonstrate the in-vivo activity of its newly created anti-inflammatory agent, Nourexin-4, in a mouse model of H1N1 influenza infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 9/3/2010: Cygilant venture capital transaction
Next: 9/6/2010: Power Tagging Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs